Suspension of trading
Centessa Pharmaceuticals plc Share Price
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.48B 5.06B 4.67B 8.86B 598B 9.01B 60.41B 23.72B 294B 23.53B 23.02B 1,012B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.33B 4.91B 4.54B 8.61B 581B 8.76B 58.71B 23.06B 286B 22.87B 22.37B 984B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 1 month | +1.84% | ||
| 3 months | +2.58% | ||
| 6 months | +80.64% | ||
| Current year | +61.94% |
| 1 month | 39.66 |  | 40.56 |
| Current year | 21.5 | | 40.56 |
| 1 year | 14.34 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2024 |
David Chao
ADM | Chief Administrative Officer | 58 | 31/03/2021 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 28/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 23/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 23/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-23 | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -9,961,789 | 6.4382% | |
| 06-23 | Issuer sale | Chief Financial Officer | -1,076,000 | 0.6954% | ||
| 06-23 | Issuer sale | Chief Technology Officer | -1,085,687 | 0.7017% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +180.67% | +454.79% | 6.27B | |
| +0.58% | +2.06% | +3.90% | +10.40% | 50.73B | |
| -2.22% | -1.25% | +391.53% | +591.38% | 39.73B | |
| -0.54% | +0.39% | +27.67% | -3.89% | 34.69B | |
| -1.36% | +0.35% | +19.34% | +58.83% | 33.21B | |
| +1.21% | -4.58% | +3.00% | +37.03% | 26.76B | |
| -1.81% | -1.48% | - | - | 16.8B | |
| +0.51% | -3.47% | +66.38% | +125.61% | 15.37B | |
| +0.23% | -0.58% | +13.80% | +19.56% | 13.78B | |
| -0.62% | -3.09% | +11.43% | -29.93% | 12.85B | |
| Average | -0.32% | -0.56% | +79.75% | +140.42% | 25.02B | |
| Weighted average by Cap. | -0.45% | -0.18% | +85.38% | +134.97% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.12 12.1 11.18 21.21 1.43K 21.57 144.6 56.78 704.76 56.32 55.1 2.42K |
| Net income | -236M -206M -190M -176M -333M -22.49B -339M -2.27B -892M -11.08B -885M -866M -38.08B | -198M -173M -159M -147M -279M -18.84B -284M -1.9B -748M -9.28B -742M -726M -31.91B |
| Net Debt | -364M -319M -294M -271M -515M -34.75B -524M -3.51B -1.38B -17.12B -1.37B -1.34B -58.85B | -176M -154M -142M -131M -249M -16.8B -253M -1.7B -667M -8.28B -662M -647M -28.46B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
